🔗 Share this article

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals said the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, risking penalties, prosecution or prison.

Service Reaction and Material Elimination

According to the social media company, the platform has removed violative content and prohibited related keywords and query recommendations. The organization said it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

After minutes of joining one group, a seller posted WhatsApp details, where most purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.

Product Information and Pricing

Within these groups, messages display black plastic packages with postal service labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.